Nouvelle déclaration d'incident
No de la demande: 2017-4474
Numéro de référence du titulaire d'homologation: USA-BAYERBAH-2017-US0028887
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer inc
Adresse: 2920 Matheson Blvd
Ville: Mississaugua
État: ON
Pays: Canada
Code postal /Zip: L4W 5R6
Incident chez un animal domestique
Pays: UNITED STATES
État: TENNESSEE
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 11556-141
Nom du produit: K9 advantix II small dog
Autre (préciser)
spot-onOui
Unités: mL
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Dog / Chien
German Spitz - Pomeranian
1
Femme
Inconnu
Inconnu
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Inconnu
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On an unknown date in approximately Dec 2016, a female, Spitz - German Pomeranian dog of unknown signalment, in unknown condition, with no known concomitant medical conditions, was administered 1 tube of K9 Advantix II Small Dog (Imidacloprid-Permethrin-Pyriproxyfen) via the topical route by the animal owner. On an unknown date in Jan 2017, the dog died. It is unknown if the dog was examined by a veterinarian or if a necropsy was performed. Due to the sensitive nature, all of the information was not obtained and no further attempts will be made to obtain the information. The owner was originally calling about a different dog and product. No further information is expected. This case is closed. Note: The intent of this call was not to report this event but to inquire on tick control for this product.
Mort
N - Unlikely Death not expected in dog after product application, as inconsistent with pharmaco-toxicological product profile. Very low level of information (age, medical history and time to onset unknown - necropsy not available) as the intent of this call was not to report this event but to inquire on tick control for this product. Other etiologies more probable. No signs of allergy/anaphylactic reaction reported. Even though time to onset unknown, occurrence of sign within window of allergic/anaphylactic reaction (within 1 day) unlikely, as would have been reported in close proximity. Considering all aspects, product connection deemed to be unlikely.